Patterson Companies, Inc. (NASDAQ:PDCO) Shares Purchased by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of Patterson Companies, Inc. (NASDAQ:PDCO) by 253.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 59,248 shares of the company’s stock after purchasing an additional 42,480 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS owned approximately 0.07% of Patterson Companies worth $1,828,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of PDCO. Harbour Investments Inc. acquired a new position in Patterson Companies during the fourth quarter worth about $26,000. GAMMA Investing LLC boosted its holdings in shares of Patterson Companies by 103.0% during the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company’s stock worth $41,000 after purchasing an additional 680 shares during the last quarter. Anchor Investment Management LLC grew its position in shares of Patterson Companies by 20.5% in the third quarter. Anchor Investment Management LLC now owns 2,350 shares of the company’s stock valued at $51,000 after purchasing an additional 400 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Patterson Companies in the third quarter valued at approximately $65,000. Finally, Blue Trust Inc. lifted its position in Patterson Companies by 18.0% during the fourth quarter. Blue Trust Inc. now owns 2,738 shares of the company’s stock worth $84,000 after buying an additional 417 shares in the last quarter. Hedge funds and other institutional investors own 85.43% of the company’s stock.

Patterson Companies Trading Up 0.1 %

Shares of NASDAQ PDCO opened at $31.24 on Wednesday. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of $2.76 billion, a PE ratio of 18.27, a PEG ratio of 2.71 and a beta of 0.99. Patterson Companies, Inc. has a twelve month low of $19.45 and a twelve month high of $31.79. The stock has a fifty day simple moving average of $31.05 and a 200-day simple moving average of $26.37.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on PDCO shares. StockNews.com started coverage on Patterson Companies in a research note on Wednesday, March 19th. They issued a “hold” rating for the company. Morgan Stanley raised their price objective on shares of Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Mizuho started coverage on shares of Patterson Companies in a report on Wednesday, December 4th. They issued a “neutral” rating and a $23.00 target price on the stock. Leerink Partnrs downgraded shares of Patterson Companies from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 11th. Finally, Robert W. Baird upped their price objective on Patterson Companies from $25.00 to $31.00 and gave the company a “neutral” rating in a report on Thursday, December 12th. Eleven investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $26.57.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.